Klotho Neurosciences (KLTO): Expected earnings per share growth for next year
The strategic goal of Klotho Neurosciences Inc (KLTO) is to monopolize neurodegeneration therapy through exclusive patents and lobbying under strict FDA oversight. This chart of the consensus EPS n+1 forecast illustrates progress in this direction, where 0.00 captures a new level. However, success depends on biological cycles rather than economics, while the absence of a product inflates R&D expenses.
Analytical breakdowns and data insights for company Klotho Neurosciences (KLTO)
- price and consensus price forecast:
- stock exchange capitalization data:
- book capitalization information:
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Klotho Neurosciences Inc|KLTO - Long-Term Debt to Capital|Short-Term Debt to Equity ANEW Medical|KLTO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Klotho Neurosciences|KLTO - Long-Term Debt|Company Short-Term Debt Klotho Neurosciences|Quick Ratio anewmeds.com
- net income and valuation ratios data:
KLTO - Net Income|Projected Future Earnings Klotho Neurosciences Inc|KLTO - Business Payback Period|Forward P/E Multiple ANEW Medical|KLTO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Klotho Neurosciences|KLTO - Operating profit before amortization|Net earnings per share (EPS TTM) Klotho Neurosciences|KLTO - Net earnings per share for the last 12 months|Quarterly EPS earnings growth anewmeds.com|KLTO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Klotho Neurosciences Inc
- issuer revenue and sales details:
Fundamental company valuation:KLTO, Klotho Neurosciences Inc
The diversification of Klotho Neurosciences Inc (KLTO) laboratories minimizes operational risks, ensuring stability in the development of neuroprotectors. This metric measures the expected earnings per share (EPS) dynamics, assessing the business's ability to scale amid rising personnel costs. A positive trend in the forward-looking net income per share growth confirms margin resilience, serving as a buy signal for the asset.
Competitors of Klotho Neurosciences Inc
Net earnings per share growth forecast for next year Biogen Corp|Expected net earnings per share growth next year Neurocrine Corp NBIX|Expected earnings per share growth for next year RGC (Regencell Bioscience)|AXSM (axsome.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|XENE: Projected earnings per share growth rate for next year|Viking Pharma - Earnings growth forecast for next year|Expected net earnings per share growth next year Supernus Corp|CPRX (Catalyst Pharmaceuticals) - Expected earnings per share growth for next year|denalitherapeutics.com (DNLI) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Harmony Biosciences Holdings, Inc.|BHVN: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Amylyx (AMLX)|TRVI - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Praxis Precision Medicines PRAX|Consensus forecast of earnings per share growth for next year anavex.com (AVXL)|CeriBell - Earnings growth forecast for next year|Prothena Corporation plc (PRTA) - Expected earnings per share growth for next year|ALEC: Earnings growth forecast for next year|ANNX - Consensus forecast of earnings per share growth for next year|OMER (Omeros Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year neurogene.com NGNE|Net earnings per share growth forecast for next year AC Immune SA (ACIU)|Voyager Therapeutics Inc - Projected earnings per share growth rate for next year|Earnings growth forecast for next year NMRA (Neumora Therapeutics Inc)|SCLX - Expected earnings per share growth for next year|Tevogen Bio Holdings - Earnings growth forecast for next year|Expected net earnings per share growth next year Alpha Cognition|Cognition Therapeutics (CGTX) - Net earnings per share growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|ASRT: Expected earnings per share trend next year|Earnings growth forecast for next year COYA|Consensus forecast of earnings per share growth for next year vistagen.com|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|ABOS: Projected earnings per share growth rate for next year|CervoMed Inc - Earnings growth forecast for next year|Alterity Therapeutics (ATHE) - Expected earnings per share growth for next year|clene.com (CLNN) - Net earnings per share growth forecast for next year|PepGen (PEPG) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Net earnings per share growth forecast for next year RLMD|Expected earnings per share growth for next year ANVS (Annovis Bio Corp)|Projected earnings per share increase next year GRCE|Net earnings per share growth forecast for next year Firefly Neuroscience, Inc AIFF|NeuroSense Therapeutics Ltd (NRSN) - Expected net earnings per share growth next year|RVPH - Net earnings per share growth forecast for next year|MTVA (MetaVia Inc) - Projected earnings per share growth rate for next year|NRXS: Earnings growth forecast for next year|Expected net earnings per share growth next year Helius Medical Technologies (HSDT)|Expected earnings per share growth for next year PASG|Earnings growth forecast for next year Neuphoria|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|ATHA (Athira Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Addex Therapeutics, Ltd. ADXN|Alzamend Neuro Inc. (ALZN) - Expected net earnings per share growth next year|CYCN - Net earnings per share growth forecast for next year|PTIX - Earnings growth forecast for next year|pasitheaclinics.com (KTTA) - Net earnings per share growth forecast for next year|CRGT (Cortigent) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Avenue Therapeutics, Inc|Expected net earnings per share growth next year BrainStorm Cell Therapeutics Inc. BCLI|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Projected earnings per share increase next year CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics Inc.)|Expected earnings per share trend next year ITCI|LBPH - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Marinus Pharma|NKGN (NKGen Biotech, Inc.) - Expected earnings per share growth for next year|neurobopharma.com - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Sage Therapeutics|Projected earnings per share growth rate for next year SNPX (Synaptogenix Inc.)|Earnings growth forecast for next year TRVN|VIGL - Expected net earnings per share growth next year|Anew Medical - Expected earnings per share growth for next year|Earnings growth forecast for next year cerevel.com CERE
